Detail akcie AngioDynamics online

Business Summary: AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Financial Summary: BRIEF: For the six months ended 30 November 2025, AngioDynamics, Inc. revenues increased 11% to $155.1M. Net loss decreased 27% to $17.3M. Revenues reflect Med Tech segment increase of 19% to $70.9M, Med Device segment increase of 4% to $84.2M, United States segment increase of 10% to $134.1M, International segment increase of 16% to $21.1M. Lower net loss reflects Plant closure decrease of 46% to $4.7M (expense).